Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You said two sexual harassers - when was NP accused of sexual harassments?
Link please.
$30k is a lot of money to many people, but the pizza store owners are part of the 13D gang. I shared a link to the legal filings against Rosenbaum, so please feel free to do the same for you accusations against Nader/Kelly.
A link to a conference call??? lol
Could you send us the link for that because I don't recall seeing that ANYWHERE.
Okay, I would suggest you go back and look at the five directors that are being proposed by Rosenbaum. He's on the list, and given that he's the 13D leader, you don't think he'll have any say on who they would choose to be the CEO???
Someone who's been accused of "As to her claims of Mr. Rosenbaum’s sexual harassment, Plaintiff purports that Mr. Rosenbaum’s “indecent proposal tying [her] receipt of a SWR check to her willingness to meet him in a hotel room was offensive, demeaning sexual harassment in one of its worst forms." shouldn't be in a position of choosing a CEO for CytoDyn.
And what about the answer to my question? Is this the leader of the 13D group that you think is a good replacement for current management?
Plaintiff asserts that in a follow-up telephone conversation, Mr. Rosenbaum affirmed his promise to repay his debt. ECF No. 10, PageID.107. Mr. Rosenbaum also allegedly told Plaintiff that “he would give her a check if she met him in person, alone, in a hotel room during her New Orleans vacation with friends or at another location of her choosing.”
"As to her claims of Mr. Rosenbaum’s sexual harassment, Plaintiff purports that Mr. Rosenbaum’s “indecent proposal tying [her] receipt of a SWR check to her willingness to meet him in a hotel room was offensive, demeaning sexual harassment in one of its worst forms."
https://law.justia.com/cases/federal/district-courts/michigan/miedce/2:2019cv12577/341333/16/
You saw the Balance Sheet??? I didn't think it had come out yet.
Please send the link.
NO, THEY'RE A FAR CRY FROM BANKRUPTCY unless the 13D gang gets their feet in the door and buys IncellDX.
So how would you suggest they, being a pre-revenue biotech, fund their trials without dilution?
HIV is a tiny market?? lol That may be a hard sell to the rest of the world.
Yeah, they have enough funds to take them through the end of the year, and another ~50m shares they can sell at any time, so bankruptcy can happen any time. lol
If that was true, the 13D gang wouldn't be struggling so much with their hostile takeover attempt. They're getting a huge number of thumbs down from the majority of investors. I wonder why that is...
YES, I AGREE THE STAFF AT CYTODYN ARE WORKING EXTREMELY HARD AND THAT IS WHY THEY NEED TO OCCASSIONALLY TAKE A LITTLE TIME OFF - THEY'VE EARNED IT.
I would suggest they not email Kelly directly because many people are on vacation this time of year, and not everyone has cell coverage. He and NP are normally VERY responsive as they've demonstrated dozens of times.
PHENOMENAL ANALYSIS OF FUTURE CYDY BINARY EVENTS by dante:
listened to the call 3 times.. a lot of info to digest. I am going to break down my analysis/hypothesis into each catalyst discussed. Firstly, that was an incredible call. It seems the team is building off each call because they seem to continually get better not just from a data standpoint but from a communication standpoint as well. Each team member vividly knows their role and they are all executing at the highest level with unimaginable workloads and pressure on them. It does seem as nadar put it they have the right synergy. You can tell the way they communicate with each other they are in sync in a higher dimensional state.
Cancer
being that most of the mTNBC data was compassionate use is hard to fathom data on this level honestly. a recent article stated that compassionate use patients have a 50% chance or more of dying. In my humble opinion I think it's more like 80-90% these patients are on there last hope, given every treatment available. The hail mary being leronlimab. To produce data that is so far better then the SOC approved in this indication is ground breaking in the field of oncology. I really don't think people are comprehending this data. When sacituzumab did there trial they had many criteria/ exclusions to effectively push the drug over the finish line and hit there primary endpoint like any company the goal is stat sig. immunomedics had 20 years of data to curate there trial. This is not the case for leronlimab. So it really is comparing apples to oranges. Leronlimab at a SIGNIFICANT disadvantage and still producing better results. As Dr.kelly stated its possible that patients could have even better outcomes if they were able to get leronlimab earlier in there cancer treatment. This was a humble way of stating what i have stated above. There is no doubt in my mind leronlimab should get BTD as no drug has ever produced data on the level cydy just presented. OH and one big thing NO SIDE EFFECTS. Hearing the anecdotal testimonies can get you emotional at times. These are patients that would be dead. If they never received leronlimab. Just that alone makes me incredibly proud to be an investor in this company. It's interesting that in the second testimony the patient was ONLY taking leronlimab and still working 60 hours a week. which made me hypothesize maybe leronlimab is working overtime with patients that are given combo leronlimab with chemo and leronlimab is actually helping fight against the negative effects of chemo maybe it would be even more effective as a mono treatment in some cases....hmmm something to think about. The bottom line cydy will be a oncology company one day. With the biggest cancer drug in the world.
long haulers
This will be the biggest indication of the century with every country in the world needing it. What makes leronlimab so powerful among many is no side effects. It's hard to justify giving a patient a treatment for long haulers with side effects. What a paradox. The data speaks for itself 21-24 symptoms are dominant. They will get BTD for long haulers. By the end of this year we will see a big pharma partnership in long haulers my guess is GSK, MERCK, or JJ. This will significantly help the company and the share price and they will be able to allocate resources to other indications.
Covid
Brazil trial starts any day now. My hypothesis CYDY knows they will hit their endpoints so they proactively are getting all the documents ready for when they do. This will expedite the EUA process when they hit stat sig. Not to mention for future trials now biome and brazil FDA has all the data/paperwork. This in general will significantly expedite trials moving forward. The wait now will be worth it in the long run. Honestly this covid trial is personal. It's time to take the FDA's soul with their disgusting letter. I AM confident leronlimab will be dominant in this trial and shock the world with the first real effective treatment. 4dose iV.
HIV
Dr.Recknor is on another level. I could tell the first time he was on a CC there's a different sense of understanding when he talks about the MOA of leronlimab. He does it humbly with a 100% fascination in the science and patients lives. Having the ROC be accepted by the FDA is a MAJOR step considering it was a needle in haystack type mission and considering the hyper failure of incelldx. People don't understand this indication alone has significant weight. When they file the full BLA in oct. This will be monumental and there will be a dynamic shift in stock price upon approval. I think we will see a HIV partnership HIV is all about marketing and cydy has too many indications to focus on. Let big pharma do what they do best MARKET.
Nash
The fastest Nash trial ever enrolled. Speaks for itself. No pharma has ever hit a primary endpoint in Nash. I can not wait for the results of the Nash trial . This is one of the biggest indications with a market value of 68 billion by 2028. UNMET MEDICAL NEED.
6. Biomarker Lab
This is going to be key and there were many subtle hints dropped when they spoke on the lab. Not only will it help advance the understanding of leronlimabs MOA for each indication but protect the overall intellectual property and the ability to patent. Each patent alone could be worth billions of dollars. Another key thing this will be CRITICAL for future trial design if the cydy team knows who,when, what dose patients should be getting leronlimab. This makes their future trials bullet proof for statistical sig. They will know before the trials starts essentially. It's interesting I submitted a question to the CC “if Dr.recknor was creating his own test for each indication”. I indirectly received my answer. Yes and this is going to be huge. Each indication with their own diagnostic companion test. I am not sure if longs picked up on multiple incelldx digs in this section. My hypothesis. Dr.recknors lab essentially makes incelldx testing for leronlimab obsolete. This CC was the beginning of the end for incelldx. Narcissism can lead you down a path of losing potentially billions of dollars. When nadar dropped “working with labcorp” this company is HUGE. They did 11 billion in revenue last year. Cydy is dealing with big dogs now. It also seems from the “one vial of blood” comment that they are figuring out they don't need advanced testing in some cases to see how leronlimab is responding in patients. This is cheap and effective. Not so good for incelldx. Another thing that is quite alarming is that Patterson knew what he was doing when he filed that patent. This leaves me with my next hypothesis. This 13D COUP has been in the works for a long time. He must have thought that nothing would ever happen when he filed that patent by the time it was granted he and the 13 D would already be running cydy. Cydy would be buying incelldx and this patent would not matter; it would be under the same umbrella. OH man that backfired. MY hypothesis incelldx could be hit with a lawsuit.. They will also lose. The icing on the cake is Cydy is going to release the failed roc letter from the FDA. tough day yesterday for incelldx and patterson. BUT in life there are consequences for disgraceful actions.
Conclusion:
Cydy team is on a hyperbolic trajectory; they have the right team and are firing on all cylinders. The 13d is a disgrace and is purely noise there won't be a vote. I have to say thank you to the 13D though before they crawled out of there swamp. Longs were very divided. Now I can honestly say 95% of longs are on the same page now with the same vision. It is beautiful to see longs come together and fight for this company as we know the cydy team is working hard for us everyday and they can not fight every battle. The research longs have done to uncover the truths about the 13D GODSPEED to you. This is bigger than a stock. CYDY will be a triple digit company one day (quote me on that). GODSPEED. TO THE GODFIGHT.
DEBUNKED - NO POTENTIAL DEATH BLOW: Upon receiving an EUA??? You mean they still haven't received an EUA for treating covid? That's counting your chickens before they hatch. But what's more interesting here is that Covid is low hanging fruit for CYDY given they completed a successful P3 trial for HIV. And cancer, including their incredible results with mTNBC, is where the money is, not covid. That's yesterday's news.
They still have 50m shares they can sell, and that's without additional authorization. Check their financials.
That doesn't make any sense given they can easily raise more funds if and when they need it.
I don't recall Nader saying "there will be no money left at the end of the year" or mentioning bankruptcy, which doesn't make any sense given they can easily raise more funds if and when they need it.
What is "tnMBC"?? Is that the word salad version of mTNBC?
Has anyone found his kindergarten records yet?
WRONG - IT IS FROM THE UNIV OF UTAH!
https://www.mech.utah.edu/pourhassan/
Try here since you can't find it:
https://www.mech.utah.edu/pourhassan/
We closed at the high for today, and we're up 31% this week. Isn't that good news?
Because "Bruce said so"?? LOL Okay, so I was right. Thanks for confirming.
You said it was "profitable", so how do you know this to be true?
I believe most people here know this is an OTC stock which prevents "most" institutional investors from buying it.
It doesn't appear to be working because we're currently at the high for this morning and still climbing. AF and the 13D gang should try another angle because this isn't working for them.
Try again...
CytoDyn’s Robust Platform Technology Keeps Expanding Into Breakthrough Therapy Designation Territory
https://microcapdaily.com/cytodyns-robust-platform-technology-keeps-expanding/132259/
CytoDyn (OTCMKTS: CYDY) has made a number of recent announcements that when examined together add up to significant progress and potential that is not reflected in the current stock price which values the company at just under $1.0 billion market cap. Looking back over the last 12 to 18 months investors have witnessed CytoDyn move from being a one trick pony for HIV to a platform technology in cancer and a slew of other indications in the immunological category, with more in the future.
(Disclosure: we hold no position in CYDY either long or short and we have not been compensated for this article.)
CytoDyn to Hold Webcast on July 22 to Discuss Results from Cancer Trials, HIV BLA Status, NASH, and COVID-19 Trials
https://www.cytodyn.com/newsroom/press-releases/detail/545/cytodyn-to-hold-webcast-on-july-22-to-discuss-results-from
LOL - The mRNA technology was used for the covid vaccines (Pfizer and Moderna). mTNBS is metastatic triple-negative breast cancer.
You do NOT use a covid vaccine for treating mNBC.
And how will the mRNA technology affect the mTNBC results? Please explain.
Yeah, if Patterson gets in, you should have plenty of opportunities to buy back in at a much lower price.
I wonder if the 30 patients and their families would agree that it's not stat sig.
I would think trashing the results of a potentially life-saving cancer drug is worse.
Yes, the results are mind-boggling and VERY encouraging.
I'm embarrassed for the shorts..especially with being up over 20%.
"CytoDyn Announces Preliminary Results from 30 mTNBC Patients Treated with Leronlimab. Decreases in CAMLs after 4 Doses of Leronlimab were Identified in Over 70% of Patients and were Associated with a 450% Significant Increase in Overall Survival at 12-Month Analysis"
This is an empty PR pump?? How is showing VERY promising results that could save the lives of tens of thousands of cancer patients "empty"?